Clinical Trials Browser

Phase EARLY_PHASE1 × Lung Neoplasms × 90 days × Clear all

NCT02676050 2026-06-03

DUAL

Phase EARLY_PHASE1 Terminated

Lung Neoplasms

NCT05873439 2026-04-01

Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

Phase EARLY_PHASE1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04298606 2026-03-17

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Phase EARLY_PHASE1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonia, Pulmonary Disease, Chronic Obstructive